Agena Bioscience® in the News

Agena Bioscience European Distributors Expand to KAWA.SKA and BioGen-Analytica

11 June 2015

SAN DIEGO, Calif., Jun. 11, 2015 — Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia.

“We are pleased to extend our partnerships with BioGen-Analytica and KAWA.SKA not only for their experience in the biotechnology market, but also for their ability to move Agena Bioscience into the clinical and diagnostic markets. We are excited to be working with both of these companies to help better meet the growing market demand from our Eastern European customer base,” said Edvin Munk, Agena Bioscience’s Vice President and Managing Director, Europe.

“We chose Agena Bioscience because the company and its MassARRAY System fits very well into KAWA.SKA’s product portfolio to provide a more comprehensive solution for our clinical customer base — from sample to results,” said Marian Kawczynski, President of KAWA.SKA.

KAWA.SKA in Poland serves hospitals, medical academies, the Polish Academy of Sciences institutes, molecular diagnostics facilities, biotechnology companies, and industrial plants.

“Agena Bioscience’s MassARRAY System aligns with the future of medical science, and has great potential in the diagnostic market in Russia,” said Dr. Andrey Glubokov, Director of BioGen-Analytica.

BioGen-Analytica in Russia serves top universities, medical academies, federal agencies including the ministry of defense, and drug developers.

Agena Bioscience’s other European distributors include Diatech Pharmacogenetics, Bio-Consult, Antisel, BioBusiness Technology, ADVANSYS, MBM Tibbi Malzemeler Tic. Ltd. Sti. and Omnivet Impex S.R.L.

The MassARRAY System detects genetic variation directly by end-point PCR and label-free mass spectrometry. Due to the high confidence level mass spectrometry provides, the MassARRAY System is used to screen for targeted biomarkers implicated in a number of clinical applications including carrier screening, oncology, pharmacogenomics, and newborn screening. The platform’s rapid and flexible assay design coupled with simple data analysis allows laboratories to develop targeted, actionable panels for routine or specialized assays with limited bioinformatics resources for as little as tens of EURO per test.

About Agena Bioscience

Agena Bioscience is a San Diego, CA based life sciences and clinical diagnostics company that recently acquired the Bioscience business of Sequenom, Inc. and is now offering the MassARRAY® System. The system is a highly sensitive, quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry for high-throughput genotyping and mutation profiling for cancer and other disease research, companion diagnostics, pharmacogenomics, molecular blood group typing, epigenetics, clinical genetics, ag-bio genetics, and molecular sample identification for bio-banking.


KAWA.SKA is based in Zalesie Górne, Poland and focuses on devices and solutions for molecular biology, biotechnology, environmental protection, molecular diagnostics and histopathology. The company serves The Polish Academy of Science, medical academies, hospitals and industrial plants. KAWA.SKA regularly organizes seminars and workshops to train and educate researchers and students.

About BioGen-Analytica

BioGen-Analytica is based in Moscow, Russia and offers high-tech solutions for a wide variety of research areas, including biology, medicine, and nanotechnology. The company specializes in equipment for biological and medical research and offers all related services and support to its customers throughout the Russian Federation.